Literature DB >> 8813117

A permanently charged tamoxifen derivative displays anticancer activity and improved tissue selectivity in rodents.

A Biegon1, M Brewster, H Degani, E Pop, D Somjen, A M Kaye.   

Abstract

A quaternized form of tamoxifen (TAM), tamoxifen methiodide (TMI), was shown to demonstrate very low brain uptake compared to TAM and, unexpectedly, was considerably less estrogenic than TAM in the uterus. The agonist activity of TMI in the bone was similar to that of TAM. TMI manifested significant dose-dependent tumoricidal activity with a rapid onset of action against MCF-7 human breast cancer implants in nude mice and a mean reduction in tumor size of 60% over six weeks.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813117

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Tamoxifen Administration Immediately or 24 Hours after Spinal Cord Injury Improves Locomotor Recovery and Reduces Secondary Damage in Female Rats.

Authors:  Jennifer M Colón; Aranza I Torrado; Ámbar Cajigas; José M Santiago; Iris K Salgado; Yaría Arroyo; Jorge D Miranda
Journal:  J Neurotrauma       Date:  2016-04-08       Impact factor: 5.269

Review 2.  International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.

Authors:  Eric R Prossnitz; Jeffrey B Arterburn
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

3.  Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.

Authors:  Yonghua Zhang; Dejan Milatovic; Michael Aschner; Paul J Feustel; Harold K Kimelberg
Journal:  Exp Neurol       Date:  2007-01-24       Impact factor: 5.330

4.  DCPIB, a specific inhibitor of volume regulated anion channels (VRACs), reduces infarct size in MCAo and the release of glutamate in the ischemic cortical penumbra.

Authors:  Yonghua Zhang; Huaqiu Zhang; Paul J Feustel; Harold K Kimelberg
Journal:  Exp Neurol       Date:  2007-12-07       Impact factor: 5.330

Review 5.  Inhibition of release of taurine and excitatory amino acids in ischemia and neuroprotection.

Authors:  Harold K Kimelberg; Nestor B Nestor; Paul J Feustel
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

6.  Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase.

Authors:  Chandramohan Wakade; Mohammad M Khan; Liesl M De Sevilla; Quan-Guang Zhang; Virendra B Mahesh; Darrell W Brann
Journal:  Endocrinology       Date:  2007-09-27       Impact factor: 4.736

7.  Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha.

Authors:  Laurivette Mosquera; Jennifer M Colón; José M Santiago; Aranza I Torrado; Margarita Meléndez; Annabell C Segarra; José F Rodríguez-Orengo; Jorge D Miranda
Journal:  Brain Res       Date:  2014-03-15       Impact factor: 3.252

Review 8.  Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury.

Authors:  Iris K Salgado; Aranza I Torrado; Jose M Santiago; Jorge D Miranda
Journal:  Neural Regen Res       Date:  2015-03       Impact factor: 5.135

9.  Delayed short-term tamoxifen treatment does not promote remyelination or neuron sparing after spinal cord injury.

Authors:  Nicole Pukos; Dana M McTigue
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

10.  Advillin Is Expressed in All Adult Neural Crest-Derived Neurons.

Authors:  Diana V Hunter; Brittney D Smaila; Douglas M Lopes; Jun Takatoh; Franziska Denk; Matt S Ramer
Journal:  eNeuro       Date:  2018-09-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.